(Q33333542)

25 July 2017

title

Evaluation of a pharmacy-based surveillance program for heparin-induced thrombocytopenia (English)

1 reference

heparin-induced thrombocytopenia

25 July 2017

1 reference

0 references

1 reference

Andreescu AC

1

1 reference

25 July 2017

Possidente C

series ordinal

2

1 reference

25 July 2017

Hsieh M

series ordinal

3

1 reference

25 July 2017

Cushman M

series ordinal

4

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

25 July 2017

1 reference

25 July 2017

volume

20

1 reference

25 July 2017

issue

8

1 reference

25 July 2017

page(s)

974-980

1 reference

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.974.35264

A 14-year study of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.974.35264

Antigen Generation in Heparin-Associated Thrombocytopenia: The Nonimmunologic Type and the Immunologic Type Are Closely Linked in Their Pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.974.35264

Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.974.35264

Characterization of the humoral immune response in heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.974.35264

Heparin-associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.974.35264

Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.974.35264

Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.974.35264

Heparin-associated thrombocytopenia (HAT)--still a diagnostic and therapeutical problem in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.974.35264

Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.11.974.35264

10.1592/PHCO.20.11.974.35264

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference